Cervical cancer kills 4,300 American women annually. Most of these deaths are preventable. Teal Health's at-home screening ...
Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from ...
Safety featured universal TEAEs and 92% grade ≥3 events; anemia (39.5%) predominated, discontinuations were frequent, and ...
MANDEVILLE, Manchester — The obstetrics and gynaecology department at Mandeville Regional Hospital has been gifted ...
Tisotumab vedotin plus carboplatin and pembrolizumab improved survival outcomes in patients with recurrent/metastatic cervical cancer.
Advances in precision medicine are reshaping the management of gynecologic cancers, with molecular profiling, biomarker-guided treatment selection, targeted ...
Almost 60% of patients met the primary endpoint of progression-free survival (PFS) at 6 months with the CDK4/6 inhibitor ...
Randomized Phase III Trial for Evaluating the Efficacy of Adjuvant Abemaciclib in Patients With Locoregional Recurrence of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative ...
3State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, P.R. China. 2Department of Obstetrics and Gynecology, Development and Related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results